Fluticasone Furoate: 100 mcg or 200 mcg
Umeclidinium: 62.5 mcg
Vilanterol: 25 mcg
Dosage Form: Dry Powder Inhaler (DPI)
Route: Oral inhalation
Typical pack: 30 inhalations, subject to product specification
Singapore's National Drug Formulary currently lists fluticasone furoate/umeclidinium/vilanterol inhalation powder in 100/62.5/25 mcg and 200/62.5/25 mcg strengths.
What Is Fluticasone Furoate + Umeclidinium + Vilanterol Inhaler?
This triple inhaler combines three complementary respiratory medicines:
Fluticasone Furoate – ICS: Helps reduce airway inflammation.
Umeclidinium – LAMA: Helps relax airway smooth muscle by blocking muscarinic activity, supporting prolonged bronchodilation.
Vilanterol – LABA: Helps relax airway muscles and maintain airway opening for prolonged bronchodilation.
Together, these mechanisms can help improve maintenance control of airflow limitation and respiratory symptoms in appropriately diagnosed patients.
Uses of Fluticasone Furoate + Umeclidinium + Vilanterol Inhaler
The combination may be prescribed as maintenance treatment for:
Chronic Obstructive Pulmonary Disease (COPD)
Chronic bronchitis associated with COPD
Emphysema associated with COPD
Asthma in eligible adult patients, depending on the approved indication in the destination country
Long-term maintenance of airway control where triple therapy is clinically appropriate
It should not be used as a rescue treatment for sudden acute bronchospasm. Patients should follow their physician's prescribed rescue-medication plan for sudden breathing difficulty.
Key Advantages
Three complementary respiratory mechanisms in one inhaler
Convenient once-daily maintenance dosing for approved products
Combines anti-inflammatory and two long-acting bronchodilator mechanisms
Designed for long-term maintenance rather than immediate rescue
Convenient DPI format
May simplify treatment compared with using separate maintenance inhalers when triple therapy is indicated
Suitable for professional healthcare and pharmaceutical supply channels, subject to destination-country regulations
Disadvantages, Precautions & Possible Side Effects
As with other prescription inhaled medicines, this product can cause adverse effects. Possible effects may include:
Headache
Sore throat
Cough
Hoarseness
Oral thrush
Dry mouth
Tremor
Palpitations or increased heart rate
Urinary retention in susceptible patients
Eye-related anticholinergic effects in susceptible individuals
Inhaled corticosteroids may increase the risk of oral candidiasis and, in susceptible patients, pneumonia. Patients should use the inhaler exactly as prescribed and maintain appropriate oral hygiene.
Important: This medicine is not intended to provide immediate relief from an acute asthma or COPD attack. Product-specific contraindications, warnings, age limits, dosing, and approved indications must be checked against the current package insert and destination-country regulatory requirements.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supporting international pharmaceutical sourcing and supply.
Why international buyers choose Cordium Pharma
✓ Pharmaceutical export support from India
✓ Product sourcing and international supply assistance
✓ Competitive B2B quotation support
✓ Support for bulk and wholesale requirements
✓ Export-oriented packaging and documentation support
✓ Communication support for international buyers
✓ Supply solutions for distributors, pharmacies, hospitals and healthcare businesses
✓ Global inquiry support for approved pharmaceutical products
Cordium Pharmaceuticals' current website identifies the company as a pharmaceutical exporter from India and provides international pharmaceutical supply services.
Target Markets for Pharmaceutical Buyers
🇸🇬 Singapore
Target cities: Singapore, Jurong, Woodlands, Tampines, Bedok, Yishun, Queenstown
🇲🇾 Malaysia
Target cities: Kuala Lumpur, Petaling Jaya, Shah Alam, Johor Bahru, Penang, George Town, Ipoh, Kuching, Kota Kinabalu
🇰🇪 Kenya
Target cities: Nairobi, Mombasa, Kisumu, Nakuru, Eldoret
🇺🇸 USA
Target cities: New York, Los Angeles, Chicago, Houston, Dallas, Miami, Atlanta, Boston, Philadelphia, San Francisco
🇬🇧 UK
Target cities: London, Birmingham, Manchester, Liverpool, Leeds, Glasgow, Edinburgh, Bristol, Cardiff, Belfast
🇦🇪 UAE
Target cities: Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain, Ras Al Khaimah
Cordium Pharma – International Enquiries
Cordium Pharmaceuticals Pvt Ltd
India
WhatsApp: +91 9405117673
Email: info@cordiumpharma.com
Umeclidinium: 62.5 mcg
Vilanterol: 25 mcg
Dosage Form: Dry Powder Inhaler (DPI)
Route: Oral inhalation
Typical pack: 30 inhalations, subject to product specification
Singapore's National Drug Formulary currently lists fluticasone furoate/umeclidinium/vilanterol inhalation powder in 100/62.5/25 mcg and 200/62.5/25 mcg strengths.
What Is Fluticasone Furoate + Umeclidinium + Vilanterol Inhaler?
This triple inhaler combines three complementary respiratory medicines:
Fluticasone Furoate – ICS: Helps reduce airway inflammation.
Umeclidinium – LAMA: Helps relax airway smooth muscle by blocking muscarinic activity, supporting prolonged bronchodilation.
Vilanterol – LABA: Helps relax airway muscles and maintain airway opening for prolonged bronchodilation.
Together, these mechanisms can help improve maintenance control of airflow limitation and respiratory symptoms in appropriately diagnosed patients.
Uses of Fluticasone Furoate + Umeclidinium + Vilanterol Inhaler
The combination may be prescribed as maintenance treatment for:
Chronic Obstructive Pulmonary Disease (COPD)
Chronic bronchitis associated with COPD
Emphysema associated with COPD
Asthma in eligible adult patients, depending on the approved indication in the destination country
Long-term maintenance of airway control where triple therapy is clinically appropriate
It should not be used as a rescue treatment for sudden acute bronchospasm. Patients should follow their physician's prescribed rescue-medication plan for sudden breathing difficulty.
Key Advantages
Three complementary respiratory mechanisms in one inhaler
Convenient once-daily maintenance dosing for approved products
Combines anti-inflammatory and two long-acting bronchodilator mechanisms
Designed for long-term maintenance rather than immediate rescue
Convenient DPI format
May simplify treatment compared with using separate maintenance inhalers when triple therapy is indicated
Suitable for professional healthcare and pharmaceutical supply channels, subject to destination-country regulations
Disadvantages, Precautions & Possible Side Effects
As with other prescription inhaled medicines, this product can cause adverse effects. Possible effects may include:
Headache
Sore throat
Cough
Hoarseness
Oral thrush
Dry mouth
Tremor
Palpitations or increased heart rate
Urinary retention in susceptible patients
Eye-related anticholinergic effects in susceptible individuals
Inhaled corticosteroids may increase the risk of oral candidiasis and, in susceptible patients, pneumonia. Patients should use the inhaler exactly as prescribed and maintain appropriate oral hygiene.
Important: This medicine is not intended to provide immediate relief from an acute asthma or COPD attack. Product-specific contraindications, warnings, age limits, dosing, and approved indications must be checked against the current package insert and destination-country regulatory requirements.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supporting international pharmaceutical sourcing and supply.
Why international buyers choose Cordium Pharma
✓ Pharmaceutical export support from India
✓ Product sourcing and international supply assistance
✓ Competitive B2B quotation support
✓ Support for bulk and wholesale requirements
✓ Export-oriented packaging and documentation support
✓ Communication support for international buyers
✓ Supply solutions for distributors, pharmacies, hospitals and healthcare businesses
✓ Global inquiry support for approved pharmaceutical products
Cordium Pharmaceuticals' current website identifies the company as a pharmaceutical exporter from India and provides international pharmaceutical supply services.
Target Markets for Pharmaceutical Buyers
🇸🇬 Singapore
Target cities: Singapore, Jurong, Woodlands, Tampines, Bedok, Yishun, Queenstown
🇲🇾 Malaysia
Target cities: Kuala Lumpur, Petaling Jaya, Shah Alam, Johor Bahru, Penang, George Town, Ipoh, Kuching, Kota Kinabalu
🇰🇪 Kenya
Target cities: Nairobi, Mombasa, Kisumu, Nakuru, Eldoret
🇺🇸 USA
Target cities: New York, Los Angeles, Chicago, Houston, Dallas, Miami, Atlanta, Boston, Philadelphia, San Francisco
🇬🇧 UK
Target cities: London, Birmingham, Manchester, Liverpool, Leeds, Glasgow, Edinburgh, Bristol, Cardiff, Belfast
🇦🇪 UAE
Target cities: Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain, Ras Al Khaimah
Cordium Pharma – International Enquiries
Cordium Pharmaceuticals Pvt Ltd
India
WhatsApp: +91 9405117673
Email: info@cordiumpharma.com
Keywords
